Psyence Historical Financial Ratios

PBMWW Stock   0.01  0.0005  6.76%   
Psyence Biomedical is promptly reporting on over 67 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Free Cash Flow Yield of 0.0, Invested Capital of 0.0, Operating Cash Flow Per Share of 0.0 or Average Payables of 771.1 K will help investors to properly organize and evaluate Psyence Biomedical financial condition quickly.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

About Psyence Financial Ratios Analysis

Psyence BiomedicalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Psyence Biomedical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Psyence financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Psyence Biomedical history.

Psyence Biomedical Financial Ratios Chart

Current Ratio is likely to drop to 0.09 in 2024. Company Equity Multiplier is likely to drop to -0.11 in 2024
Add Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
Free Cash Flow Per ShareRoic
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityRoe
Tangible Asset ValueEv To Operating Cash Flow
Pe RatioReturn On Tangible Assets
Ev To Free Cash FlowIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Research And Ddevelopement To Revenue

The ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Income Quality

An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.
Most ratios from Psyence Biomedical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Psyence Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
Current Ratio is likely to drop to 0.09 in 2024. Company Equity Multiplier is likely to drop to -0.11 in 2024

Psyence Biomedical fundamentals Correlations

-0.180.470.740.73-0.480.16-0.52-0.52-0.52-0.48-0.360.73-0.18-0.18-0.480.830.760.5-0.030.740.130.73-0.36-0.18-0.36
-0.18-0.94-0.8-0.80.91-0.340.930.930.930.890.67-0.811.01.00.89-0.70.5-0.940.06-0.8-0.32-0.810.671.00.67
0.47-0.940.940.94-0.990.48-1.0-0.99-1.0-0.98-0.780.94-0.94-0.94-0.980.88-0.210.99-0.210.940.460.94-0.78-0.94-0.78
0.74-0.80.941.0-0.920.33-0.96-0.96-0.96-0.9-0.681.0-0.8-0.8-0.90.990.120.95-0.061.00.31.0-0.68-0.8-0.68
0.73-0.80.941.0-0.920.33-0.96-0.96-0.96-0.9-0.681.0-0.8-0.8-0.90.990.120.96-0.061.00.311.0-0.68-0.8-0.68
-0.480.91-0.99-0.92-0.92-0.590.980.970.981.00.84-0.920.910.911.0-0.860.19-0.960.33-0.92-0.57-0.920.840.910.83
0.16-0.340.480.330.33-0.59-0.42-0.37-0.42-0.64-0.770.33-0.34-0.34-0.640.31-0.130.35-0.960.331.00.33-0.77-0.34-0.77
-0.520.93-1.0-0.96-0.960.98-0.421.01.00.960.75-0.960.930.930.96-0.90.16-1.00.14-0.96-0.39-0.960.750.930.75
-0.520.93-0.99-0.96-0.960.97-0.371.01.00.950.72-0.970.930.930.95-0.910.15-1.00.08-0.96-0.35-0.970.720.930.72
-0.520.93-1.0-0.96-0.960.98-0.421.01.00.960.75-0.960.930.930.96-0.90.16-1.00.14-0.96-0.39-0.960.750.930.75
-0.480.89-0.98-0.9-0.91.0-0.640.960.950.960.86-0.910.890.891.0-0.850.18-0.940.39-0.9-0.62-0.910.860.890.86
-0.360.67-0.78-0.68-0.680.84-0.770.750.720.750.86-0.680.670.670.86-0.640.16-0.710.6-0.68-0.76-0.681.00.671.0
0.73-0.810.941.01.0-0.920.33-0.96-0.97-0.96-0.91-0.68-0.81-0.8-0.910.990.110.96-0.061.00.311.0-0.68-0.81-0.68
-0.181.0-0.94-0.8-0.80.91-0.340.930.930.930.890.67-0.811.00.89-0.70.5-0.940.06-0.8-0.32-0.810.671.00.67
-0.181.0-0.94-0.8-0.80.91-0.340.930.930.930.890.67-0.81.00.89-0.70.5-0.940.06-0.8-0.32-0.80.671.00.67
-0.480.89-0.98-0.9-0.91.0-0.640.960.950.961.00.86-0.910.890.89-0.850.18-0.940.39-0.9-0.62-0.910.860.890.86
0.83-0.70.880.990.99-0.860.31-0.9-0.91-0.9-0.85-0.640.99-0.7-0.7-0.850.270.9-0.060.990.280.99-0.64-0.7-0.64
0.760.5-0.210.120.120.19-0.130.160.150.160.180.160.110.50.50.180.27-0.180.060.12-0.140.110.160.50.16
0.5-0.940.990.950.96-0.960.35-1.0-1.0-1.0-0.94-0.710.96-0.94-0.94-0.940.9-0.18-0.070.950.330.96-0.71-0.94-0.71
-0.030.06-0.21-0.06-0.060.33-0.960.140.080.140.390.6-0.060.060.060.39-0.060.06-0.07-0.06-0.96-0.060.60.060.6
0.74-0.80.941.01.0-0.920.33-0.96-0.96-0.96-0.9-0.681.0-0.8-0.8-0.90.990.120.95-0.060.31.0-0.68-0.8-0.68
0.13-0.320.460.30.31-0.571.0-0.39-0.35-0.39-0.62-0.760.31-0.32-0.32-0.620.28-0.140.33-0.960.30.31-0.76-0.32-0.76
0.73-0.810.941.01.0-0.920.33-0.96-0.97-0.96-0.91-0.681.0-0.81-0.8-0.910.990.110.96-0.061.00.31-0.68-0.81-0.68
-0.360.67-0.78-0.68-0.680.84-0.770.750.720.750.861.0-0.680.670.670.86-0.640.16-0.710.6-0.68-0.76-0.680.671.0
-0.181.0-0.94-0.8-0.80.91-0.340.930.930.930.890.67-0.811.01.00.89-0.70.5-0.940.06-0.8-0.32-0.810.670.67
-0.360.67-0.78-0.68-0.680.83-0.770.750.720.750.861.0-0.680.670.670.86-0.640.16-0.710.6-0.68-0.76-0.681.00.67
Click cells to compare fundamentals

Psyence Biomedical Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Psyence Stock Analysis

When running Psyence Biomedical's price analysis, check to measure Psyence Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence Biomedical is operating at the current time. Most of Psyence Biomedical's value examination focuses on studying past and present price action to predict the probability of Psyence Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence Biomedical's price. Additionally, you may evaluate how the addition of Psyence Biomedical to your portfolios can decrease your overall portfolio volatility.